Surgical Science Sweden AB (publ) (SUSRF)
USD 12.75
(0.0%)
USD 12.75
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 23.51 Million | 12.36 Million | 4.3 Million | 2.82 Million | 5.89 Million | 775.78 Thousand |
| Net Income | 23.09 Million | 17.95 Million | 9.49 Million | 1.9 Million | 1.34 Million | -509.7 Thousand |
| Depreciation & Amortization | 5.48 Million | 4.16 Million | 2.89 Million | 1.24 Million | 1.62 Million | 238.66 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -557.95 Thousand | -6.26 Million | -5.14 Million | -711.22 Thousand | 2.73 Million | 157.79 Thousand |
| Other non-cash items | -4.5 Million | -3.48 Million | -2.94 Million | 390.86 Thousand | 196.66 Thousand | 1.2 Million |
| Investing Cash Flow | -4.35 Million | -3.29 Million | -300.86 Million | -1.05 Million | -22.46 Million | -974.18 Thousand |
| Investments in PPE | -4.35 Million | -3.29 Million | -1.58 Million | -1.05 Million | -952.35 Thousand | -974.18 Thousand |
| Acquisitions | - | - | -299.27 Million | - | -21.51 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -33.67 Million | - | -1.00 | - | -1.00 | - |
| Financing Cash Flow | 1.56 Million | 1.63 Million | 321.76 Million | 512.02 Thousand | 19.84 Million | 215.65 Thousand |
| Debt repayment | -201.54 Thousand | -1.63 Million | -2.66 Million | -1.32 Million | -1.08 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.88 Million | - | 325.25 Million | 1.13 Million | 20.28 Million | 177.76 Thousand |
| Other Financing Activities | -2.04 Million | 3.26 Million | -831.58 Thousand | 695.49 Thousand | 651.11 Thousand | 37.89 Thousand |
| Accounts receivables | 3.14 Million | -6.75 Million | -9.31 Million | 226.6 Thousand | 2.45 Million | -450.15 Thousand |
| Accounts payables | -1.77 Million | 2.56 Million | 3.46 Million | -296.01 Thousand | 537.65 Thousand | 191.4 Thousand |
| Inventory | -1.93 Million | -2.07 Million | 711.13 Thousand | -641.82 Thousand | -260.54 Thousand | 416.54 Thousand |
| Other working capital | -1.00 | 1.00 | 2.00 | - | - | - |
| Cash at beginning of period | 41.42 Million | 34.86 Million | 10.61 Million | 7.39 Million | 4.34 Million | 4.7 Million |
| Cash at end of period | 62.61 Million | 41.42 Million | 34.86 Million | 10.61 Million | 7.39 Million | 4.34 Million |
| Capital Expenditure | -4.35 Million | -3.29 Million | -1.58 Million | -1.05 Million | -952.35 Thousand | -974.18 Thousand |
| Effect of forex changes on cash | -9.37 Million | 5.02 Million | 591 Thousand | -796 Thousand | 42 Thousand | -192 Thousand |
| Net cash flow / Change in cash | 21.19 Million | 6.55 Million | 24.25 Million | 3.21 Million | 3.05 Million | -364.52 Thousand |
| Free Cash Flow | 19.16 Million | 9.06 Million | 2.72 Million | 1.76 Million | 4.94 Million | -198.4 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.68 Million | 25.97 Million | 23.09 Million | 9.66 Million | 4.32 Million | 3.58 Million |
| Depreciation & Amortization | 1.35 Million | 1.38 Million | 5.48 Million | 1.39 Million | 1.29 Million | 1.27 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.6 Million | -14.12 Million | -557.95 Thousand | -1.45 Million | -1.36 Million | 2.78 Million |
| Other non-cash items | 4.69 Million | 4.46 Million | -4.5 Million | -5.69 Million | 595.35 Thousand | 216.81 Thousand |
| Investing Cash Flow | -1.17 Million | -10.4 Million | -4.35 Million | -1.15 Million | -1.46 Million | -866.78 Thousand |
| Investments in PPE | -1.17 Million | -10.4 Million | -4.35 Million | -1.15 Million | -1.46 Million | -866.78 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -10.29 Million | -922.65 Thousand | - | -824.07 Thousand | -1000.00 | -598.75 Thousand |
| Financing Cash Flow | -625.37 Thousand | -2.56 Million | 1.56 Million | 885.04 Thousand | -463.02 Thousand | 1.36 Million |
| Debt repayment | -671.38 Thousand | -66.68 Thousand | -201.54 Thousand | -26.64 Thousand | -58.73 Thousand | -406.83 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.88 Million | - | - | 1.76 Million |
| Other Financing Activities | -7.15 Million | -714 Thousand | -2.04 Million | 271 Thousand | -404.29 Thousand | -405.1 Thousand |
| Accounts receivables | -1.09 Million | -1.12 Million | 3.14 Million | -3.28 Million | 2.32 Million | 3.8 Million |
| Accounts payables | 656.92 Thousand | 523.22 Thousand | -1.77 Million | -144.79 Thousand | -3.93 Million | 1.59 Million |
| Inventory | -1.16 Million | -7.69 Million | -1.93 Million | 1.97 Million | 249.24 Thousand | -2.6 Million |
| Other working capital | 6.99 Million | 524.63 Thousand | -1.00 | -1.00 | 1.00 | 1.00 |
| Cash at beginning of period | 61.56 Million | 634.36 Million | 41.42 Million | 55.27 Million | 53.01 Million | 46.23 Million |
| Cash at end of period | 62.63 Million | 659.18 Million | 62.61 Million | 62.61 Million | 55.27 Million | 53.01 Million |
| Capital Expenditure | -1.17 Million | -10.4 Million | -4.35 Million | -1.15 Million | -1.46 Million | -866.78 Thousand |
| Effect of forex changes on cash | -2.94 Million | 9.29 Million | -9.37 Million | -8.5 Million | -327 Thousand | 1.87 Million |
| Net cash flow / Change in cash | 1.07 Million | 24.81 Million | 21.19 Million | 7.33 Million | 2.25 Million | 6.78 Million |
| Free Cash Flow | 1.64 Million | 18.08 Million | 19.16 Million | 2.74 Million | 3.37 Million | 6.98 Million |
PUTKY
MI6
BNET
CSXXY
AMNPLST
TATASTEEL